Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Single-Dose Fazamorexant vs Zolpidem in Healthy Young and Elderly Chinese Subjects
NCT06685341Phase 1Completed
- Sponsor
- Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
- Start
- Mar 2019
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of fazamorexant in Insomnia (4 arms), sponsored by Shanghai Haiyan Pharmaceutical Technology Co., Ltd. Primary endpoints: Maximum Plasma Concentration, Area Under the Curve to Infinity and 13 more. Started Mar 2019; status: completed.
02
Drugs
fazamorexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT06685341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06685341.